Drugs Made In America Acquisition (DMAAR) Accounts Payables (2024 - 2025)
Drugs Made In America Acquisition (DMAAR) reported Accounts Payables of $222184.0 for Q4 2025, up 187.51% on a YoY basis from $77280.0 in Q4 2024, and up 22118.4% quarter-over-quarter from $1000.0 in Q2 2025.
Drugs Made In America Acquisition (DMAAR) Accounts Payables (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition has reported Accounts Payables for 2 years, with the latest figure at $222184.0 in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables rose 187.51% year-over-year to $222184.0; the trailing twelve-month figure through Dec 2025 stood at $222184.0 (up 187.51% YoY), and the FY2025 full-year result was $222184.0, up 187.51% from the prior year.
- Accounts Payables for Q4 2025 stood at $222184.0, up from $1000.0 in the prior quarter.
- The five-year high for Accounts Payables was $222184.0 in Q4 2025, with the low at $1000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | 167,813.00 |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 144,789.00 |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 50,877.00 |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 39,602.00 |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 1.13 Mn |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | - |
| 10 | Drugs Made In America Acquisition | - | - | - | 222,184.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 222,184.00 |
| Jun 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 77,280.00 |